PPARA and colonic neoplasm: Nonhepatic Cancers. The only evidence that PPARα may potentially behave as a tumor suppressor downregulated by aberrantly expressed miRNAs in transformed cells comes from a study performed in a drug-resistant colon cancer cell line (SW1116) showing that miR-506 overexpression in this cancer cell model directly affects PPARα expression [38].